Optimization of Diltiazem hydrochloride osmotic formulation using QBD approach
DOI:
https://doi.org/10.1590/s2175-97902022e19779%20Keywords:
Elementary osmotic pump, QbD, Factorial design, Tablet, Zero orderAbstract
Diltiazem hydrochloride (DLH) is a calcium channel blocker useful for the treatment of angina pectoris, arrhythmia, and hypertension. DLH having a short half-life needs frequent administration for successful treatment but this poses a problem of poor patient compliance. These requirements are served by elementary osmotic pump tablets (EOP) based controlled-release (CR) systems. Quality by design (QbD) approach assists in screening various factors with subsequent assessment of critical parameters that can have a major impact on the scalability of EOP. Tablets were formulated using wet granulation method followed by osmotic coating. Factorial design based QbD strategy aided in defining the risk assessment of influential variables such as hydrophilic polymers and osmotic coat component on the in-vitro release kinetics of the designed EOP tablets. These formulated EOP systems followed zero-order kinetics, a characteristic feature of EOPs. EOP tablets were formulated applying a systematic QbD statistical approach. The formulated DLH EOP systems with improved concentration-independent behavior helped to address the challenges of IR formulation. Application of QbD strategy in ascertaining the scalability of DLH EOP formulation would help pharmaceutical industries in the translation of EOP based drug delivery systems from R&D to market.
Downloads
References
Bonthagarala B, Dasari V, Kotra V, Swain S, Beg S. Quality-by-Design based development and characterization of pioglitazone loaded liquisolid compact tablets with improved biopharmaceutical attributes. J Drug Deliv Sci Technol. 2019;51:045-055.
CARDIZEM® CD (diltiazem HCl) label
Debnath S, Aishwarya MNL, Iranajan M. Formulation by design: An approach to designing better drug delivery systems. Pharm Times. 2018;50(8):9-14.
Desai N, Purohit R. Design and development of clopidogrel bisulfate gastroretentive osmotic formulation using quality by design tools. AAPS Pharm Sci Tech. 2017;18(7):2626-2638.
Fukuda IM, Pinto CFF, Moreira CDS, Saviano AM, Lourenço FR. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Braz J Pharm Sci. 2018;54(n° spe):1-16.
Guittard GV, Wong PSL, Theeuwes F, Cortese R. Method for delvering dosage form for dilteazem. 1990;4966769.
Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Controlled Release. 2001;73(2-3):121-136.
International council for harmonisation of technical requirements for registration of pharmaceuticals for human use. Pharmaceutical Development Q8(R2), in: ICH Harmonised Tripartite Guideline. 2009; pp. 1-28.
Kenjale PP, Joshi MA, Khatavkar UN, Dhapte VV, Pokharkar VB. Paroxetine hydrochloride push-pull osmotic pump tablets: designing an innovative, scalable push-pull osmotic drug delivery system using QbD approach. Drug Delivery Lett. 2019;10(2):104-116.
Kundawala A, Sheth P, Maheshwari D. Sandwiched osmotic tablet for controlled release of metoprolol succinate. J Pharm Investig. 2016;46:29-40.
Lee AR, Kwon SY, Choi DH, Park ES. Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo®) manufactured via high shear wet granulation. Int J Pharm. 2017;534(1-2):144-158.
Listiohadi Y, Hourigan JA, Sleigh RW, Steele RJ. Moisture sorption , compressibility and caking of lactose polymorphs. Int J Pharm . 2008;359(1-2):123-134.
Malaterre V, Ogorka J, Loggia N, Gurny R. Oral osmotically driven systems: 30 years of development and clinical use. Eur J Pharm Biopharm. 2009;73(3):311-323.
Naga GM, Madhusudan RY. Formulation and evaluation Tramadol hydrochloride elementary osmotic pumps. Int J Pharm Res Biomed Anal. 2016;5:01-09.
Patel A, Dodiya H, Shelate P, Shastri D, Dave D. Design, characterization, and optimization of controlled drug delivery system containing antibiotic drug/s. J Drug Deliv. 2016;1-15.
Phaechamud T, Darunkaisorn W. Drug release behavior of polymeric matrix filled in capsule. Saudi Pharm J. 2016;24(6):627-634.
Prabakaran D, Singh P, Kanaujia P, Vyas SP. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm . 2003;259(1-2):173-179.
Sangshetti JN, Deshpande M, Arote R, Zaheer Z, Shinde DB. Quality by design approach: Regulatory need. Arab J Chem. 2014.(in press)
Shah HP, Prajapati ST. Quality by design based development and optimization of novel gastroretentive floating osmotic capsules of clopidogrel bisulfate. J Pharm Investig . 2019;49:295-311.
Siepmann F, Hoffmann A, Leclercq B, Carlin B, Siepmann J. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Controlled Release . 2007;119(2):182-189.
Siepmann J, Siepmann F. Modeling of diffusion controlled drug delivery. J Controlled Release . 2012;161(2):351-362.
Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding Pharmaceutical Quality by Design. AAPS J. 2014;16(4):771-783.
Zhang L, Mao S. Application of Quality by Design in the current drug development. Asian J Pharm Sci. 2016.(in press)
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
